Categories Articles FDA Panel Narrowly Backs Pfizer RSV Vaccine for Older Adults Post author By crystalg Post date March 1, 2023 TIME Tags Adults, Backs, Narrowly, Older, panel, Pfizer, Vaccine ← Teaching children self-control in elementary school leads to well-educated, successful adults → How to watch Tesla’s 2023 Investor Day event